Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Down 5.1% in January

Assertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 5,730,000 shares, a decrease of 5.1% from the January 15th total of 6,040,000 shares. Based on an average trading volume of 754,900 shares, the short-interest ratio is currently 7.6 days.

Assertio Stock Up 0.3 %

ASRT stock traded up $0.00 during mid-day trading on Friday, hitting $0.81. The stock had a trading volume of 248,544 shares, compared to its average volume of 393,605. The company has a current ratio of 2.01, a quick ratio of 1.57 and a debt-to-equity ratio of 0.30. Assertio has a 1-year low of $0.73 and a 1-year high of $1.80. The company has a fifty day moving average of $0.84 and a 200 day moving average of $1.01. The stock has a market capitalization of $77.61 million, a price-to-earnings ratio of -1.11, a PEG ratio of 3.21 and a beta of 0.76.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Palumbo Wealth Management LLC increased its position in Assertio by 9.3% in the 3rd quarter. Palumbo Wealth Management LLC now owns 185,961 shares of the company's stock worth $219,000 after purchasing an additional 15,863 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of Assertio by 33.7% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 67,500 shares of the company's stock valued at $59,000 after acquiring an additional 17,000 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Assertio by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 1,095,911 shares of the company's stock valued at $955,000 after acquiring an additional 21,059 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of Assertio by 5.4% during the 3rd quarter. Empowered Funds LLC now owns 431,913 shares of the company's stock valued at $510,000 after acquiring an additional 21,976 shares during the last quarter. Finally, Captrust Financial Advisors acquired a new position in shares of Assertio during the 3rd quarter valued at about $26,000. 48.96% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ASRT. HC Wainwright reissued a "buy" rating and issued a $4.00 price objective on shares of Assertio in a research note on Monday, December 16th. StockNews.com raised Assertio from a "hold" rating to a "buy" rating in a research note on Wednesday, November 13th.

Assertio Company Profile

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.